Lack of tumor specificity decreased its suitability for tumor targeting as reflected by the TASC score of 17 compared to 21 out of 22 for TEM1 (62) and FAP assessed in our study with 22 in human, 21 in feline, and 18 in canine STSs. This evidence concerns the gene FAP and neoplasm.